Invention Grant
- Patent Title: 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
-
Application No.: US16016955Application Date: 2018-06-25
-
Publication No.: US10583139B2Publication Date: 2020-03-10
- Inventor: Dominique Amans , Stephen John Atkinson , Lee Andrew Harrison , David Jonathan Hirst , Robert Peter Law , Matthew Lindon , Alexander Preston , Jonathan Thomas Seal , Christopher Roland Wellaway
- Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Yun Wang
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/497 ; C07D401/14 ; A61K31/4709 ; A61K31/496 ; C07D498/08 ; A61K31/5377 ; A61K31/5386 ; A61K31/4375 ; A61K31/4706 ; C07D498/04 ; C07D487/08 ; C07D471/08 ; C07D471/04 ; C07D471/14 ; C07D471/12 ; C07D413/12 ; C07D405/14 ; C07D413/14 ; C07D215/227 ; C07D215/46 ; C07D215/48 ; C07D401/04 ; C07D401/12 ; C07D405/04 ; C07D409/12 ; C07D409/14 ; C07D413/04 ; C07D417/12 ; C07D417/14 ; C07D215/44
Abstract:
The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
Public/Granted literature
Information query
IPC分类:
